Robert Casey actually said...

"But my question is, why stop at insulin?"

"I think there is a consensus, when we go back home, we hear from people about the cost of prescription drugs."

"We need it and we need notification both with drugs and devices, not only when manufacturing is disrupted, but also when there is a huge surge in demand."

"It will be a huge issue among many difficult issues in this reauthorization."